Navigation Links
MGuard(TM) Coronary Stent System Approved in Israel
Date:12/8/2008

TEL AVIV, Israel, December 8 /PRNewswire/ -- InspireMD, Ltd. announced that the MGuard(TM) coronary stent system has been approved for use in Israel by the Israeli Ministry of Health.

The MGuard(TM) stent system presents a novel combination of a coronary stent merged with an embolic protection device. Lifelong embolic protection is achieved by an expandable, flexible fishnet style, micron level knit sleeve that wraps the stent. In addition, MGuard(TM) blocks embolic showers and plaque detachment from the arterial wall, blocking debris at the source during and post procedure. The net is designed to diffuse stent pressure on the vessel wall, thereby reducing injury and lowering the likelihood of restenosis. Since MGuard(TM) received CE Mark approval in November 2007 the product has been met with much enthusiasm and celebrated by leading interventional cardiologists worldwide. "We are very excited about MGuard(TM) being approved for use in Israel so soon" stated Dr. Asher Holzer, InspireMD's President. "Our leading Israeli Interventional Cardiologists have been eager to have this life saving stent system available at their hospitals and already in the few days since the local approval, lives of Israelis have been saved with MGuard(TM)". MGuard's relatively early regulatory approval in Israel may have been partly due to numerous recommendations by local opinion leaders to the Ministry of Health.

InspireMD will celebrate the launch of MGuard(TM) in Israel at the upcoming ICI '08 Meeting in Tel-Aviv, December 8th-9th where MGuard(TM) will be demonstrated at booth #18. In addition, InspireMD will be hosting an inspiring cocktail reception symposium on December 8th at the ICI Meeting, MGuard(TM): A Unique Solution for Managing Embolic Complications in Acute MI and SVG. Martin Leon MD and Chaim Lotan MD will chair the meeting where additional speakers include key world renowned interventional cardiologists Martin Rothma
'/>"/>

SOURCE InspireMD, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
2. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
3. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
4. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
5. Surgery More Likely Than Angioplasty to Relieve Pain for Patients With Coronary Artery Disease
6. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
7. Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
8. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
9. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
10. CorNova Preclinical Results of Valecor Platinum(TM) Coronary Stent Studies Presented at TCT 2007 Conference
11. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... ORANGEBURG, N.Y. , June 2, 2015 /PRNewswire/ ... products and solutions, today announced a series of ... customers about strategies to reduce the threat of ... with the US Centers for Disease Control and ... House,s National Strategy to Combat Antibiotic-Resistant Bacteria. ...
(Date:6/2/2015)... 02, 2015 Research and Markets ( ... PharmaBiotech,s new report "Drug Delivery in Central ... to their offering. The delivery ... a challenge in the treatment of neurological disorders. ... or administered systematically (e.g., by intravenous injection) for ...
(Date:6/2/2015)... June 2, 2015 The Canadian Society for Vascular ... tests, treatments or procedures that are commonly ordered ... part of Choosing Wisely Canada.  The list identifies ... conversations between patients and physicians about what care ... for Vascular Surgery,s list identified the following five ...
Breaking Medicine Technology:PDI Partners with White House and Centers for Disease Control and Prevention (CDC) to Combat Antimicrobial Resistance 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 2As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 4
... July 28, 2011 Roka Bioscience, Inc. announced today ... equity financing, raising $20 million in new capital. The ... since the company,s formation in September 2009. The investor ... Advisors, New Enterprise Associates, Inc., TPG Biotech and Gen-Probe ...
... spending growth slowed from an estimated 5.3 percent in ... data released today by the Centers for Medicare and ... Researchers credit the slowdown in spending growth to pharmacy ... toward lower cost generic drugs. Pharmaceutical Care Management ...
Cached Medicine Technology:Roka Bioscience Completes $20 Million Series C Financing 2PCMA: Study Credits PBM Tools with Reducing Prescription Drug Spending Growth 2
(Date:6/2/2015)... UCLA Health and Exer have completed negotiations and ... urgent care services in Los Angeles County. The ... California Board of Regents and the Exer Board of ... purchase a minority share of four existing Exer urgent ... Northridge and creates opportunity to grow and develop new, ...
(Date:6/2/2015)... New Jersey (PRWEB) June 02, 2015 ... (Horizon BCBSNJ) announced today that its Walking and Wellness ... Classic Presented by Acer, has raised another $3,000 for ... Natalie Gulbis undertook the challenge, recording 32,000 steps on ... at Stockton Seaview Hotel & Golf Club in Galloway ...
(Date:6/2/2015)... June 02, 2015 Bitscape Infotech today ... 2015 Microsoft Worldwide Small and Midsized Cloud Solutions Award. ... top Microsoft partners for demonstrating excellence in innovation and ... , “This comes as no surprise to us as ... year consecutively at worldwide level by Microsoft. We will ...
(Date:6/2/2015)... Radaris ” was featured on NewsWatch as part of its ... coolest applications on the market for iOS, Android, and Windows. ... the app review and shared with viewers can help users ... According to Psychology Today, humans are a curious species by ... is a part of human development. People are using the ...
(Date:6/2/2015)... 02, 2015 Tronics, a designer and ... growth strategy to benefit from the significant growth expected ... May 2015 Status of the MEMS Industry report, we ... reach $6.6B in 2020,” says Frederic Breussin, Business Unit ... , The analyst adds that “although the BioMEMS market ...
Breaking Medicine News(10 mins):Health News:UCLA Health Partners With Exer - More Than Urgent Care 2Health News:LPGA’s Natalie Gulbis Raises an Additional $3,000 for the Boys & Girls Club of Atlantic City Through Horizon BCBSNJ’s Walking and Wellness Challenge 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 3Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2Health News:Tronics Aims to Benefit from Major Growth of Sensors and Related Technologies for Healthcare Applications 2
... finds city-dwelling females have more dense breasts, , , MONDAY, Nov. ... appear to have more dense breast tissue than their suburban ... potentially important because women with more dense breasts have a ... compared rural women from Greece to suburban and urban women ...
... a smoking gun, but its smoking-related, and its there ... deep in the lungs, caused by secondhand cigarette smoke. ... to nonsmokers that was long suspected, but not previously ... suggest that their findings may strengthen public health efforts ...
... For the first time, researchers have identified structural ... , The results of the study, conducted by ... in Charlottesville and The Childrens Hospital of Philadelphia in ... the Radiological Society of North America (RSNA). , Its ...
... clinical professor of neurology at Boston University School of ... Study, was recently awarded the Stroke Council Award from ... at the AHAs recent Scientific Sessions meeting in Orlando, ... encourages those who actively work to integrate stroke and ...
... at Yale and Cornell have created a modified chemotherapy ... of brain tumors by adding a water-soluble polymer ... the November-December issue of Bioconjugate Chemistry. , This approach ... than a centimeter, which may be sufficient to prevent ...
... Imaging, a,wholly owned subsidiary of Mercury Computer Systems, ... Siemens Medical Solutions to deliver advanced,3D visualization and ... Siemens will integrate Visage Imaging,s advanced 3D ... This unique thin client-based,image distribution solution will be ...
Cached Medicine News:Health News:Urban Women May Have Greater Breast Cancer Risk 2Health News:Urban Women May Have Greater Breast Cancer Risk 3Health News:Secondhand smoke damages lungs, MRIs show 2Health News:Novel MRI technique shows secondhand smoke damages lungs 2Health News:New method of drug delivery more effective at reaching brain tumors 2Health News:Visage Imaging Expands Availability of Its Advanced Visualization Offering 2Health News:Visage Imaging Expands Availability of Its Advanced Visualization Offering 3
Concave inner surface to conform to the globe. Used in conjunction with the E5381 600 Circling Band (240 style). Indications: Wide scleral bed. Outside diameter 31.7 mm....
Used in conjunction with the E5381 700 Circling Band (240 style). Indications: Narrow scleral bed. Overall length: 100 mm, 3.9 inches....
Used in conjunction with the E5381 600 Circling Band (40 style). Indications: Massive retinal breaks. Inner diameter: 26 mm....
Used in conjunction with the E5381 600 Circling Band (40 style). Indications: Narrow scleral bed. Overall length: 100 mm, 3.9 inches....
Medicine Products: